Document is current
Any future updates will be listed below
-
Authors
Nowak, R. G.
Gough, E.
Holm, J. H.
Hu, F.
Akinyombo, K.
Okudo, C.
Ozumba, P. J.
Jonathan, E. C.
Tiamiyu, A. B.
Kokogho, A.
Adebajo, S. B.
Shoyemi, E.
Baral, S. D.
Lombardi, K.
Peel, S.
Lim, J. N.
Gaydos, C. A.
Manabe, Y. C.
Sears, C. L.
Shardell, M.
Ravel, J.
Crowell, T. A.
Tuddenham, Susan
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Allergy and Infectious Diseases (R21AI156765)
National Institute of Mental Health (R01MH099001)
U.S. President’s Emergency Plan for AIDS Relief
U.S. Department of Defense
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 24 February 2026
First Online: 5 March 2026
Competing interests
: ST has been a consultant for Biofire Diagnostics, Roche Molecular Diagnostics and Luca Biologics, receives royalties from UpToDate and has received speaker honoraria from Roche Molecular Diagnostics and Medscape/WebMD. She participates in research supported by in-kind donation of test kits from Hologic. CG reports consultations for Rover, Dx Inc; Autonomous Medical Devices, Inc; Binx Health, Inc; and BioMedical Insights. C.L.S. has received research funding to Johns Hopkins University from Bristol-Myers Squibb and Janssen, and royalties from Up to Date outside the submitted work. All the remaining authors declare no conflict of interest.
